CRH posts $30.5M in revenue for Q2 2019 — 6 insights

CRH Medical continues to bring in the revenue in 2019, posting $30.5 million in second quarter revenues, up from $27.3 million in the same period last year.

Advertisement

What you should know:

1. CRH’s operating income was $4.6 million, with a 15 percent operating income margin.

2. The company’s adjusted operating EBITDA was $13.3 million, with a 44 percent adjusted operating EBITDA margin.

3. CRH increased its caseload to 84,656 patients in the second quarter, up from 77,501 patients in the first quarter.

4. The company’s net and comprehensive income attributable to shareholders was $1.6 million.

5. CRH’s adjusted operating EBITDA attributable to shareholders was $9.7 million.

6. The company’s net cash provided by operating activities was $9.6 million.

CRH CEO Tushar Ramani, MD, said, “Executing on current initiatives, CRH is poised to further build on this growth heading into the second half of 2019 and beyond.”

More articles on surgery centers: 
Looser ASC requirements, 24-hour stays & more: 3 regulation updates to know
Becoming an administrator & what separates ASCs from one another — 2 insights from a recruiter
Hospital-owned ASC doesn’t get tax exemption, Pennsylvania court says 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.